Literature DB >> 14521409

Trisubstituted acridine derivatives as potent and selective telomerase inhibitors.

R John Harrison1, Javier Cuesta, Gianni Chessari, Martin A Read, Sanji K Basra, Anthony P Reszka, James Morrell, Sharon M Gowan, Christopher M Incles, Farial A Tanious, W David Wilson, Lloyd R Kelland, Stephen Neidle.   

Abstract

The synthesis and evaluation for telomerase-inhibitory and quadruplex DNA binding properties of three related series of rationally designed trisubstituted acridine derivatives are described. These are substituted on the acridine ring at the 2,6,9; 2,7,9; and 3,6,9 positions. The ability of several of the most potent compounds to interact with and stabilize an intramolecular G-quadruplex DNA was evaluated by surface plasmon resonance methods, and affinities were found to correlate with potency in a telomerase assay. The interactions of a number of compounds with a parallel quadruplex DNA structure were simulated by molecular modeling methods. The calculated interaction energies were compared with telomerase activity and showed generally consistent correlations between quadruplex affinity and telomerase inhibition. These data support a model for the action of these compounds that involves the stabilization of intermediate quadruplex structures that inhibit the elongation of telomeric DNA by telomerase in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521409     DOI: 10.1021/jm0308693

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  28 in total

1.  Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter.

Authors:  Thomas S Dexheimer; Daekyu Sun; Laurence H Hurley
Journal:  J Am Chem Soc       Date:  2006-04-26       Impact factor: 15.419

2.  Rational design of substituted diarylureas: a scaffold for binding to G-quadruplex motifs.

Authors:  William C Drewe; Rupesh Nanjunda; Mekala Gunaratnam; Monica Beltran; Gary N Parkinson; Anthony P Reszka; W David Wilson; Stephen Neidle
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

3.  Targeting human telomerase for cancer therapeutics.

Authors:  Lionel Guittat; Patrizia Alberti; Dennis Gomez; Anne De Cian; Gaëlle Pennarun; Thibault Lemarteleur; Chafke Belmokhtar; Rajaa Paterski; Hamid Morjani; Chantal Trentesaux; Eliane Mandine; François Boussin; Patrick Mailliet; Laurent Lacroix; Jean-François Riou; Jean-Louis Mergny
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

4.  The biological activity of G-quadruplex DNA binding papaverine-derived ligand in breast cancer cells.

Authors:  Blazej Rubis; Mariusz Kaczmarek; Natalia Szymanowska; Elzbieta Galezowska; Andrzej Czyrski; Bernard Juskowiak; Tadeusz Hermann; Maria Rybczynska
Journal:  Invest New Drugs       Date:  2008-09-05       Impact factor: 3.850

5.  New insights from molecular dynamic simulation studies of the multiple binding modes of a ligand with G-quadruplex DNA.

Authors:  Jin-Qiang Hou; Shuo-Bin Chen; Jia-Heng Tan; Hai-Bin Luo; Ding Li; Lian-Quan Gu; Zhi-Shu Huang
Journal:  J Comput Aided Mol Des       Date:  2012-12-13       Impact factor: 3.686

6.  Recognition and discrimination of DNA quadruplexes by acridine-peptide conjugates.

Authors:  James E Redman; J M Granadino-Roldán; James A Schouten; Sylvain Ladame; Anthony P Reszka; Stephen Neidle; Shankar Balasubramanian
Journal:  Org Biomol Chem       Date:  2008-10-30       Impact factor: 3.876

7.  Targeting human telomeric G-quadruplex DNA with oxazole-containing macrocyclic compounds.

Authors:  Daniel S Pilch; Christopher M Barbieri; Suzanne G Rzuczek; Edmond J Lavoie; Joseph E Rice
Journal:  Biochimie       Date:  2008-04-04       Impact factor: 4.079

8.  Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small molecule.

Authors:  Mekala Gunaratnam; Stephen Swank; Shozeb M Haider; Katja Galesa; Anthony P Reszka; Monica Beltran; Francisco Cuenca; Jonathan A Fletcher; Stephen Neidle
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

9.  Inhibition of human telomerase activity by an engineered zinc finger protein that binds G-quadruplexes.

Authors:  Sachin D Patel; Mark Isalan; Gérald Gavory; Sylvain Ladame; Yen Choo; Shankar Balasubramanian
Journal:  Biochemistry       Date:  2004-10-26       Impact factor: 3.162

10.  Towards Profiling of the G-Quadruplex Targeting Drugs in the Living Human Cells Using NMR Spectroscopy.

Authors:  Daniel Krafčík; Eva Ištvánková; Šimon Džatko; Pavlína Víšková; Silvie Foldynová-Trantírková; Lukáš Trantírek
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.